Quest Diagnostics, Inc [DGX] stock is trading at $159.97, up 3.02%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The DGX shares have gain 5.80% over the last week, with a monthly amount glided 4.60%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Quest Diagnostics, Inc [NYSE: DGX] stock has seen the most recent analyst activity on January 06, 2025, when Leerink Partners upgraded its rating to a Outperform and also boosted its price target to $174 from $169. Previously, Morgan Stanley upgraded its rating to Overweight on December 17, 2024, and elevated its price target to $172. Robert W. Baird upgraded its rating to a Outperform and increased its price target to $182 on October 23, 2024. Citigroup upgraded its rating to Buy for this stock on July 10, 2024, and upped its price target to $165. In a note dated February 26, 2024, Leerink Partners initiated an Market Perform rating and provided a target price of $135 on this stock.
Quest Diagnostics, Inc [DGX] stock has fluctuated between $123.04 and $165.32 over the past year. Currently, Wall Street analysts expect the stock to reach $171.86 within the next 12 months. Quest Diagnostics, Inc [NYSE: DGX] shares were valued at $159.97 at the most recent close of the market. An investor can expect a potential return of 7.43% based on the average DGX price forecast.
Analyzing the DGX fundamentals
Quest Diagnostics, Inc [NYSE:DGX] reported sales of 9.54B for the trailing twelve months, which represents a growth of 8.41%. Gross Profit Margin for this corporation currently stands at 0.32% with Operating Profit Margin at 0.14%, Pretax Profit Margin comes in at 0.12%, and Net Profit Margin reading is 0.09%. To continue investigating profitability, this company’s Return on Assets is posted at 0.05, Equity is 0.13 and Total Capital is 0.09. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.02.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 157.01 points at the first support level, and at 154.05 for the second support level. However, for the 1st resistance point, the stock is sitting at 161.49, and for the 2nd resistance point, it is at 163.02.
Ratios To Look Out For
For context, Quest Diagnostics, Inc’s Current Ratio is 1.25. In addition, the Quick Ratio stands at 1.17 and the Cash Ratio stands at 0.37. Considering the valuation of this stock, the price to sales ratio is 1.87, the price to book ratio is 2.63 and price to earnings (TTM) ratio is 21.47.
Transactions by insiders
Recent insider trading involved PREVOZNIK MICHAEL E, SVP & General Counsel, that happened on Nov 29 ’24 when 35146.0 shares were sold. EVP, Regional Businesses, Doherty Catherine T. completed a deal on Nov 27 ’24 to sell 33103.0 shares. Meanwhile, Officer PREVOZNIK MICHAEL E bought 35146.0 shares on Nov 29 ’24.
